Postoperative analgesia and anxiety and depression
Conditions
Interventions
S group:Sufentanil 2.0ug/kg+ palonosetron 0.25mg
Sponsors
Affiliated Hospital of Guizhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Aged 18 to 65 years; 2.ASA I-II; 3.Male or female; 4.No preoperative diseases of vital organs, no cardiopulmonary, liver and kidney dysfunction, no history of chronic system, no history of cerebrovascular disease, no history of mental illness, no history of drug abuse, no recent use of analgesic drugs such as opioids and non-steroidal an-inflammatory drugs (NSAIDs); 5.Patients who did not participate in other clinical trials preoperatively; 6.Preoperative diagnosis and imaging examination of the patients with clear lung mass lesions, to be thoracoscopic lobectomy under general anesthesia.
Exclusion criteria
Exclusion criteria: 1.Patients with hyperthyroidism; 2.Cognitive dysfunction; 3.Allergy to the drug used in this study; 4.Intolerance to one-lung ventilation, history of rib fracture, history of iplateral lung surgery or trauma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital Anxiety and Depression Scale;Ramsay sedation Scale;Press of PCA;Analgesic satisfaction; | — |
Countries
China
Contacts
Public ContactZou Xiaohua
Affiliated Hospital of Guizhou Medical University
Outcome results
None listed